Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-02-21 @ 4:58 AM
Study NCT ID:
NCT02574533
Status:
COMPLETED
Last Update Posted:
2017-09-27
First Post:
2015-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma
Sponsor:
Organization: